Active — Not RecruitingNot Applicable

A Clinical Trial to Evaluate the Effects of Super Lungs Liquid Drops on Respiratory Comfort, Airway Soothing, and Overall Well-Being

United States35 participantsStarted 2026-07-02

Plain-language summary

This is a single-group, open-label, fully decentralized (virtual) clinical trial evaluating the effects of Super Lungs Liquid Drops on respiratory comfort, airway soothing, and overall well-being in generally healthy adults aged 18-65 who experience bothersome respiratory symptoms. All 35 enrolled participants will receive the active study product and self-administer 2 mL of the drops daily (two full droppers of 1 mL each, once daily with the first meal of the day) for 12 weeks.

Who can participate

Age range

18 Years – 65 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Adults aged 18-65 years. * Over the past two months, has experienced bothersome coughing on a weekly basis. * Anyone who has experienced issues with at least two of the following over the past four weeks: chest tightness or congestion; persistent throat irritation or itchiness; excess mucus or phlegm buildup. * Generally healthy, without any uncontrolled chronic disease. * Willing to maintain their current diet, sleep pattern, and activity levels for the duration of the trial. * Resides in the United States. * Has access to the internet and a device (smartphone, tablet, or computer) capable of completing online questionnaires. * Willing to follow the study protocol and complete all required assessments. Exclusion Criteria: * Anyone with a known allergy or sensitivity to any of the study product ingredients. * Anyone with a known allergy to plants in the Asteraceae/Compositae family. * Women who are pregnant, breastfeeding, or planning to become pregnant during the study period. * Anyone currently taking immunosuppressant medications (e.g., cyclosporine, methotrexate, biologics such as adalimumab or infliximab). * Anyone with a diagnosed autoimmune disorder (e.g., lupus, rheumatoid arthritis, multiple sclerosis). * Anyone with uncontrolled hypertension or currently taking antihypertensive medications, diuretics, or corticosteroids. * Anyone currently taking anticoagulant or antiplatelet medications (e.g., warfarin, heparin, clopidogrel). * Anyone with …

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Respiratory comfort

Timeframe: Baseline, Week 2, Week 4, Week 8, and Week 12

Normal airway function

Timeframe: Baseline, Week 2, Week 4, Week 8, and Week 12

Trial details

NCT IDNCT07694284

SponsorSuperBonsai Inc.

Sponsor typeINDUSTRY

Study typeINTERVENTIONAL

Primary completion2026-08

View on ClinicalTrials.gov More Coughing trials